Search Results 151-160 of 16535 for Acrivastine

  1. Ramipril (oral route) - Side effects & dosage - Mayo Clinic

    This lowers blood pressure and increases the supply of blood and oxygen to the heart. This medicine is available only with your doctor's prescription. This ...

  2. Isatuximab-irfc (intravenous route) - Side effects & uses - Mayo Clinic

    Isatuximab-irfc injection is used in combination with pomalidomide and dexamethasone to treat multiple myeloma (a type of bone marrow cancer) in patients who ...

  3. Brivekimig For The Treatment Of Moderate To Severe Hidradenitis Suppurativa - Mayo Clinic

    About this study. This is a Phase 2b, global, multicenter, sequential, randomized, double-blind, placebo-controlled, parallel group, dose-ranging study in ...

  4. Sevabertinib (oral route) - Side effects & dosage - Mayo Clinic

    Your doctor will perform a test before you take this medicine. Sevabertinib belongs to the group of medicines called antineoplastics (cancer medicines). It ...

  5. Carboprost (intramuscular route) - Side effects & dosage - Mayo Clinic

    Carboprost is given by injection to cause abortion. It is an oxytocic, which means it acts by causing the uterus to contract the way it does during labor and ...

  6. Revefenacin (inhalation route) - Mayo Clinic

    It relieves cough, wheezing, and troubled breathing by increasing the flow of air through the bronchial tubes. This medicine is available only with your ...

  7. A Study Of Radiation Dosimetry, Safety, And Tolerability Of Extended Lutetium (177Lu) Vipivotide Tetraxetan Treatment In Chemo-naïve Adults With Metastatic Castration-resistant Prostate Cancer

    A Study Of Radiation Dosimetry, Safety, And Tolerability Of Extended Lutetium (177Lu) Vipivotide Tetraxetan Treatment In Chemo-naïve Adults With Metastatic ...

  8. A Phase 1b/2 Study of Onvansertib (PCM-075) in Combination with FOLFIRI and Bevacizumab for Second-Line Treatment of Metastatic Colorectal Cancer in Patients with a KRAS Mutation - Mayo Clinic

    Participants must have histologically confirmed metastatic and unresectable disease, and previously failed treatment or be intolerant to fluoropyrimidine and ...

  9. A Phase 2 Study of Atezolizumab (an Engineered Anti-PDL1 Antibody) as Monotherapy or in Combination With Avastin (Bevacizumab) Compared to Sunitinib in Patients With Untreated Advanced Renal Cell Carcinoma [IMmotion150] - Mayo Clinic

    A Phase 2 Study of Atezolizumab (an Engineered Anti-PDL1 Antibody) as Monotherapy or in Combination With Avastin (Bevacizumab) Compared to Sunitinib in Patients ...

  10. Capivasertib (oral route) - Side effects & dosage - Mayo Clinic

    Capivasertib is used in combination with fulvestrant to treat HR-positive, HER-2 negative breast cancer that is advanced or metastatic (cancer that has spread) ...